References
- Smith L, Kelly KD, Prkachin G, Voaklander DC. The prevalence of cerebral palsy in British Columbia: 1991–1995. Canadian Journal of Neurological Sciences 2008; 35: 342–347
- Mutch L, Alberman E, Hagberg B, Kodama K, Perat MV. Cerebral palsy epidemiology: Where are we now and where are we going?. Developmental Medicine Child Neurology 1992; 34: 547–551
- Palisano RJ, Rosenbaum P, Walter S, Russell DJ, Wood EP, Galuppi BE. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Developmental Medicine Child Neurology 1997; 39: 214–223
- Morris C, Bartlett D. Gross Motor Function Classification System: Impact and utility. Developmental Medicine Child Neurology 2004; 46: 60–65
- Heinen F, Desloovere K, Schroeder AS, Berweck S, Borggraefe I, van Campenhout A, Anderson GL, Aydin R, Becher JG, Bernert G, et al. The updated European Consensus 2009 on the use of Botlimnum toxin for children with cerebral palsy. European Journal of Paediatric Neurology 2010; 14: 45–66
- Wynter M, Gibson N, Kentish M, Love S, Thomason P, Graham HK. The consensus statement on Hip Surveillance for Children with Cerebral Palsy: Australian Standards of Care. Journal of Pediatric Rehabilitation Medicine 2011; 4: 183–195
- Morris C, Galuppi B, Rosenbaum P. Reliability of family report for the Gross Motor Function Classification System. Developmental Medicine Child Neurology 2004; 46: 455–460
- Ko J, Woo J, Her J. The reliability and concurrent validity of the GMFCS for children with cerebral palsy. Journal of Physical Therapy Science 2011; 23: 255–258
- Bodkin AW, Robinson C, Perales FP. Reliability and validity of the Gross Motor Function Classification System for Cerebral Palsy. Pediatric Physical Therapy 2003; 15: 247–252
- Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159–174